Please login to the form below

Not currently logged in
Email:
Password:

Flucelvax

This page shows the latest Flucelvax news and features for those working in and with pharma, biotech and healthcare.

GSK gets OK for second quadrivalent flu vaccine in US

GSK gets OK for second quadrivalent flu vaccine in US

Instead, the Swiss firm has focused its R&D investment on switching from egg-based to cell culture-based production, securing approval for its FluCelVax product in November 2012.

Latest news

  • GSK's four-strain flu vaccine debuts in the US GSK's four-strain flu vaccine debuts in the US

    Novartis has concentrated on developing cell-manufactured flu vaccines, having recently won approval in the US for its Flucelvax trivalent candidate, and is arguably lagging in the quadrivalent stakes.

  • Novartis gets US approval for Flucelvax flu jab made in cells Novartis gets US approval for Flucelvax flu jab made in cells

    It added that, unlike conventional flu vaccines, Flucelvax does not contain preservative such as thimerosal. ... Flucelvax will be produced in Holly Springs once the facility is ready for full-scale commercial production," said Novartis in a statement.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics